A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (25 mg eq, 50 mg eq, and 100 mg eq) of Paliperidone Palmitate in Patients With Schizophrenia
收藏DataCite Commons2025-02-06 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004610/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine the efficacy (how well the drug works), safety, and side effects of paliperidone palmitate compared to placebo in the treatment of the symptoms of schizophrenia in adults. The placebo used in this study was a nutritional substance known as 20% Intralipid emulsion given to patients requiring intravenous feedings.
提供机构：
Vivli
创建时间：
2019-09-19
